These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3121470)

  • 41. [Antiocoagulant activity of chondroitin sulfate A, B and C.--co-operative action with heparin cofactor (author's transl)].
    Shiba T; Takeuchi S; Awazu S; Igarashi M; Asada T
    Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):560-3. PubMed ID: 696196
    [No Abstract]   [Full Text] [Related]  

  • 42. Experimental studies on the relative efficacy of dermatan sulphate and heparin as antithrombotic agents.
    Merton RE; Thomas DP
    Thromb Haemost; 1987 Oct; 58(3):839-42. PubMed ID: 3433248
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular and functional heterogeneity in dermatan sulfate preparations.
    Fareed J; Hoppensteadt D; Walenga JM; Ahsan A; Coyne E; Breddin HK
    Semin Thromb Hemost; 1991; 17 Suppl 2():174-80. PubMed ID: 1948088
    [No Abstract]   [Full Text] [Related]  

  • 44. The endothelium, platelets, and brain ischemia.
    Caplan LR; Fisher M
    Rev Neurol Dis; 2007; 4(3):113-21. PubMed ID: 17943063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of flavonoids on blood-vessel wall interactions.
    Beretz A; Cazenave JP
    Prog Clin Biol Res; 1988; 280():187-200. PubMed ID: 3051026
    [No Abstract]   [Full Text] [Related]  

  • 46. Dermatan sulfate as a potential antithrombotic drug.
    Pangrazzi J; Gianese F
    Haematologica; 1987; 72(5):459-64. PubMed ID: 3121470
    [No Abstract]   [Full Text] [Related]  

  • 47. A survey of the clinical experience with dermatan sulfate.
    Gianese F; Lucchelli PE
    Semin Thromb Hemost; 1991; 17 Suppl 2():199-204. PubMed ID: 1948090
    [No Abstract]   [Full Text] [Related]  

  • 48. A rationale for targeting antithrombotic therapy at the vessel wall: improved antithrombotic effect and decreased risk of bleeding.
    Buchanan MR; Brister SJ
    Wien Klin Wochenschr; 1999 Feb; 111(3):81-9. PubMed ID: 10093889
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overview of hemostasis and thrombosis; current status of antithrombotic therapies.
    Horne M
    Thromb Res; 2005; 117(1-2):15-7; discussion 39-42. PubMed ID: 16055174
    [No Abstract]   [Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.